CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock
CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock
Recruiting · NCT05267886 · Registry updated 2026-05-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock | Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, Shock, Cardiogenic, cardiovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorder | Recruiting | Phase 4 | 2026-05-01 | NCT05267886 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ottawa Heart Institute Research Corporation | 64 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hamilton Health Sciences | Hamilton | Canada | 14 |
| Mayo Clinic | Rochester | United States | 664 |
| University of Ottawa Heart Institute | Ottawa | Canada | 10 |